Design of Anti-Bacterial Drug and Anti-Mycobacterial Drug for Drug Delivery System
Author: Yanagihara, K.
Source: Current Pharmaceutical Design, Volume 8, Number 6, 1 March 2002 , pp. 475-482(8)
Publisher: Bentham Science Publishers
Abstract:
Liposome-encapsulated drugs often exhibit reduced toxicity and have also been shown to enhance retention of drugs in the tissues. Thus, encapsulation of drugs in liposomes has often resulted in an improved overall therapeutic efficacy. The results of efficacy of liposome-encapsulated ciplofloxacin or azithromycin for therapy of intracellular M. avium infection show enhanced cellular delivery of liposome-encapsulated antibiotics and suggest that efficiency of intracellular targeting is sufficient to mediate enhanced antimycobacterial effects. The antitubercular drugs encapsulated in lung specific stealth liposomes have enhanced efficacies against tuberculosis infection in mice. These results from stealth liposome study indicate that antitubercular drugs encapsulated in liposome may provide therapeutic advantages over the existing chemotherapeutic regimen for tuberculosis. Liposomes with encapsulated amikacin are able to protect collagen almost completely from adherence of bacterial cells of all strains examined and prevent from invading of bacteria.Keywords: anti-bacterial drug; anti-mycobacterial drug; mycobacterium avium infection; mycobacterium tuberculosis infection; staphylococcus aureus infection; pseudomonas aeruginosa
Document Type: Review article
DOI: http://dx.doi.org/10.2174/1381612023395808
Publication date: 2002-03-01
- Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
- In this: publication
- By this: publisher
- In this Subject: Pharmacology
- By this author: Yanagihara, K.

Shopping cart
Receive new issue alert
Get Permissions